Samantha Nunley
Family · Bluefield, WVNPI 1396128112
Payments from drug & device makers
Across 392 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$830
- AstraZeneca$725
- Amgen$627
- Lilly USA, LLC$599
- GSK$440
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,844100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 74 | $1,193 |
| Novo Nordisk | 46 | $830 |
| AstraZeneca | 40 | $725 |
| Amgen | 34 | $627 |
| Lilly USA, LLC | 37 | $599 |
| GSK | 29 | $440 |
| Boehringer Ingelheim | 25 | $422 |
| Bayer | 21 | $291 |
| Gilead | 14 | $276 |
| Exact Sciences | 9 | $199 |
| Novartis | 9 | $162 |
| Merck | 9 | $141 |
| Pfizer | 7 | $136 |
| Alnylam Pharmaceuticals Inc. | 1 | $109 |
| Mylan Specialty L.p. | 4 | $88 |
| Xeris Pharmaceuticals, Inc. | 4 | $75 |
| Biohaven Pharmaceuticals, Inc. | 3 | $55 |
| Idorsia Pharmaceuticals US Inc | 3 | $53 |
| Amarin Pharma, Inc. | 3 | $50 |
| Verona Pharma, Inc. | 2 | $49 |
| Astellas Pharma US Inc | 2 | $47 |
| Dexcom, Inc. | 3 | $44 |
| Johnson & Johnson | 2 | $43 |
| Hologic Sales And Service, LLC | 2 | $34 |
| Abbott | 1 | $25 |
| Shield Therapeutics Inc | 1 | $20 |
| Viatris Specialty LLC | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Vifor Pharma, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,844 in reported general payments places this provider in the 95th percentile of 1,507 family providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 80 | $92,794 |
| OzempicSemaglutide | 77 | $75,906 |
| JanuviaSitagliptin Phosphate | 65 | $65,629 |
| JardianceEmpagliflozin | 65 | $62,612 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 63 | $54,881 |
| TrulicityDulaglutide | 48 | $53,727 |
| FarxigaDapagliflozin Propanediol | 54 | $48,045 |
| EliquisApixaban | 48 | $36,534 |
| KerendiaFinerenone | 31 | $35,884 |
| TradjentaLinagliptin | 13 | $18,826 |
| XareltoRivaroxaban | 23 | $15,123 |
| LinzessLinaclotide | 25 | $14,359 |
| SymbicortBudesonide/Formoterol Fumarate | 35 | $12,867 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 25 | $12,489 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $9,749 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $599 | $146,522128 claims |
| Boehringer IngelheimJardiance, Tradjenta | $422 | $81,43878 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $440 | $78,303115 claims |
| Novo NordiskOzempic | $830 | $75,90677 claims |
| MerckJanuvia, Belsomra | $141 | $70,02276 claims |
| AstraZenecaFarxiga, Symbicort | $725 | $60,91389 claims |
| PfizerEliquis | $136 | $36,53448 claims |
| BayerKerendia | $291 | $35,88431 claims |
| Johnson & JohnsonXarelto | $43 | $15,12323 claims |
| AbbVieLinzess | $1,193 | $14,35925 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,507 family providers in West Virginia.
Other family in Bluefield
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
- Amber DuncanCross Lanes$44K
- Jennifer FieldsHuntington$32K
- Gina LatheyScott Depot$31K
- Jodi BillerScott Depot$29K
- Misty BareboHuntington$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.